Long-Term Follow-up on an Intensified Treatment Regimen for Advanced Resectable Head and Neck Squamous Cell Carcinomas

REFERENCES

• Kramer S., Gelber R. D., Snow J. B., et al. Combined Radiation and Surgery in the Management of Advanced Head and Neck Cancer: Final Report of Study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg. 1987; 10: 19–30
   PubMedGoogle Scholar
• Fu K. Combined-Modality Therapy for Head and Neck Cancer. Oncology 1997; 11(12)1781–1796
   PubMedGoogle Scholar
• Schuller D., Metch B., Stien D. W., et al. Preoperative Chemotherapy in Advanced Resectable Head and Neck Cancer: Final Report of the Southwest Oncology Group. Laryngoscope 1988; 98: 1205–1211
   PubMed Web of Science ®Google Scholar
• Laramore G. E., Scott C. B., Al-Sarraf M., et al. Adjuvant Chemotherapy for Resectable Squamous Cell Carcinomas of the Head and Neck: Report on Intergroup study 0034. Int. J. Radiat. Oncol. Biol. Phys. 1992; 23: 705–713
   PubMed Web of Science ®Google Scholar
• Wolf G., Vikram B., Jacobs C., et al. Adjuvant Chemotherapy for Advanced Head and Neck Squamous Carcinoma: Final Report of the Head and Neck Contracts Program. Cancer 1987; 60: 301–311
   PubMed Web of Science ®Google Scholar
• American Joint Committee on Cancer. Head and Neck. Manual for Staging of Cancer, O. H. Beahrs, D. E. Henson, R. V.P. Hutter, B. J. Kennedy. 4th Ed., J.B. Lippincott, Philadelphia 1992; 27–44
   Google Scholar
• Au J. L., Li D., Gan Y., Gao X., Johnson A. L., Johnston J., et al. Pharmacodynamics of Immediate and Delayed Effects of Paclitaxel: Role of Slow Apoptosis and Intracellular Drug Retention. Cancer Res. 1998; 59(10)2141–2148
   Google Scholar
• Gan Y., Wientjes M. G., Au J. L. Relationship Between Paclitaxel Activity and Pathobiology of Human Solid Tumors. Clin. Cancer Res. 1998; 4(12)2949–2955
   PubMed Web of Science ®Google Scholar
• Johnson A. L., Johnston J. S., Grecula J. C., Schuller D. E., Au J. L. Additive Cytotoxicity of Taxol and Radiation in Human Head and Neck Cancer Cells. Proc. Am. Assoc. Cancer Res. 1996; 37: 609, (abstract)
   Google Scholar
• Johnson A. L., Schuller D. E., Johnston J. S., Grecula J. C., Au J L-S. Interaction of Taxol, Radiation, and Cisplatin in Human Head and Neck Cancer Cells. International Conference on Head and Neck Cancer, TorontoCanada, 1996; 234: 117, (abstract)
   Google Scholar
• Gan Y., Wientjes G., Schuller D., Au J. Pharmacodynamics of Taxol in Human Head and Neck Tumors. Cancer Res. 1996; 56(9)1961–2236
   PubMedGoogle Scholar
• Cox J. D., Stetz J., Pajak T. F. Toxicity Criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research & Treatment of Cancer (EORTC). Int. J. Radiat. Oncol. Biol. Phys. 1995; 31(5)1341–1346
   PubMed Web of Science ®Google Scholar
• Green S., Weiss G. R. Southwest Oncology Group Standard Response Criteria, Endpoint Definitions, and Toxicity Criteria. Invest. New Drugs 1992; 10(94)239–253
   PubMedGoogle Scholar
• Rentschler R. E., Wilbur D. W., Petti G. H., et al. Adjuvant Methotrexate Escalated to Toxicity for Resectable Stage III and IV Squamous Head and Neck Carcinomas—A Prospective, Randomized Study. J. Clin. Oncol. 1987; 5: 278–285
   PubMed Web of Science ®Google Scholar
• Richard J. M., Kramer A., Molinari R., et al. A Randomized EORTC Head and Neck Cooperative Group Trial of Preoperative Intra-Arterial Chemotherapy in Oral Cavity and Oropharynx Carcinoma. Eur. J. Cancer 1991; 27: 821–827
   PubMed Web of Science ®Google Scholar
• Lefebvre J. L., Chevalier D., Luboinski B., et al. Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase II Trial: EORTC Head and Neck Cancer Cooperative Group. J. Natl. Cancer Inst. 1996; 88: 890–899
   PubMed Web of Science ®Google Scholar
• Jotay A., Demard F., Dalesio O., et al. A Randomized EORTC Study on the Effect of Preoperative Polychemotherapy in Pyriform Sinus Carcinoma Treated by Pharyngolaryngectomy and Irradiation: Results from 5 to 10 Years. Acta Chir. Belg. 1990; 90: 115–122
   PubMedGoogle Scholar
• Depondt J., Gehanno P., Martin M., et al. Neoadjuvant Chemotherapy with Carboplatin/5 Fluorouracil in Head and Neck Cancer. Oncology 1993; 50: 23–27
   PubMed Web of Science ®Google Scholar
• Lo T. C., Wiley A. L., Ansfield F. J., et al. Combined Radiation Therapy and 5 Fluorouracil for Advanced Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: A Randomized Study. Am. J. Roentgenol. 1976; 126: 229–235
   PubMed Web of Science ®Google Scholar
• Shanta V., Krshnamurthi S. Combined Bleomycin and Radiotherapy in Oral Cancer. Clin. Radiol. 1980; 31: 617–620
   PubMed Web of Science ®Google Scholar
• Fu K. K., Phillips T. L., Siverberg I. J., et al. Combined Radiotherapy and Chemotherapy with Bleomycin and Methotrexate for Advanced Inoperable Head and Neck Cancer: Update of a Northern California Oncology Group Randomized Trial. J. Clin. Oncol. 1987; 5: 1410–1418
   PubMed Web of Science ®Google Scholar
• Gupta N. K., Pointon R. C., Wilkinson P. M. A Randomized Clinical Trial to Contrast Radiotherapy with Radiotherapy and Methotrexate Given Synchronously in Head and Neck Cancer. Clin. Radiol. 1987; 38: 575–581
   PubMed Web of Science ®Google Scholar
• Weissberg J. B., Son Y. H., Papac R. J., et al. Randomized Clinical Trial of Mitomycin C as an Adjunct to Radiotherapy in Head and Neck Cancer. Int. J. Radiat. Oncol. Biol. Phys. 1989; 17: 3–9
   PubMed Web of Science ®Google Scholar
• Sanchiz F., Milla A., Torner J., et al. Single Fraction Per Day Versus Two Fractions Per Day Versus Radiochemotherapy in the Treatment of Head and Neck Cancer. Int. J. Radiat. Oncol. Biol. Phys. 1990; 19: 1347–1350
   PubMed Web of Science ®Google Scholar
• Bachaud J. M., Cohen–Jonathan E., Alzien C., et al. Combined Postoperative Radiotherapy and Weekly Cisplatin Infusion for Locally Advanced Head and Neck Carcinoma: Final Report of a Randomized Trial. Int. J. Radiat. Oncol. Biol. Phys. 1996; 36: 999–1004
   PubMed Web of Science ®Google Scholar
• Haffty B. G., Son Y. H., Sasaki C. T., et al. Mitomycin C as an Adjunct to Postoperative Radiation Therapy in Squamous Cell Carcinoma of the Head and Neck: Results from Two Randomized Clinical Trials. Int. J. Radiat. Oncol. Biol. Phys. 1993; 27: 241–250
   PubMed Web of Science ®Google Scholar
• Smid L., Lesnicar H., Zakotnik B., et al. Radiotherapy Combined with Simultaneous Chemotherapy with Mitomycin C and Bleomycin for Inoperable Head and Neck Cancer—Preliminary Report. Int. J. Radiat. Oncol. Biol. Phys. 1995; 32: 769–775
   PubMed Web of Science ®Google Scholar
• Adelstein D. J., Saxton J. P., Lavertu P., et al. A Phase III Randomized Trial Comparing Concurrent Chemotherapy and Radiotherapy with Radiotherapy Alone in Resectable Stage III and IV Squamous Cell Head and Neck Cancer: Preliminary Results. Head Neck 1997; 19(7)567–575
   PubMed Web of Science ®Google Scholar
• Wendt T. G., Grabenbauer G. G., Rodel C. M., et al. Simultaneous Radiochemotherapy Versus Radiotherapy Alone in Advanced Head and Neck Cancer: A Randomized Multicenter Study. J. Clin. Oncol. 1998; 16(4)1318–1324
   PubMed Web of Science ®Google Scholar
• Brizel D. M., Albers M. E., Fisher S. R., Scher R. L., et al. Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer. N. Engl. J. Med. 1998; 338(25)1798–1804
   PubMed Web of Science ®Google Scholar
• Al-Sarraf M., Le Blanc M., Giri P. G., et al. Chemo-radiotherapy vs. Radiotherapy in Patients with Locally Advanced Nasopharyngeal Cancer: Phase III Randomized Intergroup study (0099) (SWOG 8892, RTOG 8817, ECOG 2388). J. Clin. Oncol. 1998; 16(4)1310–1317
   PubMed Web of Science ®Google Scholar
• Al-Sarraf M., Pajak T. F., Byhardt R. W., et al. Postoperative Radiotherapy with Concurrent Cisplatin Appears to Improve Locoregional Control of Advanced, Resectable Head and Neck Cancers: RTOG 88-24. Int. J. Radiat. Oncol. Biol. Phys. 1997; 37(4)777–782
   PubMed Web of Science ®Google Scholar
• Carde P., Laval F. Effects of Cis-dichlorodiammeplatinum II and X-rays on Mammalian Cell Suvival. Int. J. Radiat. Oncol. Biol. Phys. 1981; 7: 929–933
   PubMed Web of Science ®Google Scholar
• Wallner K. E., Li G. C. Effect of Cisplatin Resistance on Cellular Radiation Response. Int. J. Radiat. Oncol. Biol. Phys. 1987; 13: 587–591
   PubMed Web of Science ®Google Scholar
• Fu K. K., Lam K. N., Rayner P. A. The Influence of Time Sequence of Cisplatin Administration and Continuous Low Dose Rate Irradiation on the Combined Effects on a Murine Squamous Cell Carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 1985; 11: 2119–2124
   PubMed Web of Science ®Google Scholar
• Schuller D., Grecula J., Gahbauer R., et al. Intensified Regimen for Advanced Head and Neck Squamous Cell Carcinomas. Arch. Otolaryngol. Head Neck Surg. 1997; 123: 139–144
   PubMed Web of Science ®Google Scholar